MedTrace Logo

4-week Seaweed Supplementation on Menopause Symptoms and Psychological Wellbeing

NCT05759936 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-03-21

No results posted yet for this study

Summary

Menopausal symptoms have a substantial effect on quality of life as well as potentially serving as markers for future health. Previous research has suggested that diet can impact menopausal symptoms. Seaweed is marketed as a treatment to alleviate menopause symptoms, but no research has tested whether it is effective in reducing the symptoms and psychological effects associated with menopause.

The aim of this study is to investigate the effects of consuming a seaweed supplement over a 4-week time period on menopausal symptoms and psychological well-being.

Conditions

  • Menopausal Syndrome
  • Menopausal Depression

Interventions

DIETARY_SUPPLEMENT

500mg seaweed

4 week supplementation of 1 capsule per day of seaweed

OTHER

Placebo

4 week placebo supplement of 1 capsule per day

Sponsors & Collaborators

  • Doctor Seaweed

    collaborator UNKNOWN

  • Northumbria University

    lead OTHER

Principal Investigators

  • Crystal Haskell-Ramsay · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-20
Primary Completion
2023-12-12
Completion
2023-12-12

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05759936 on ClinicalTrials.gov